CEO Dr Leearne Hinch said, “Our EXO-OC test addresses a critical unmet need for early detection of ovarian cancer. INOVIQ is now positioned as a global leader in exosome technology, offering best-in-class exosome isolation and diagnostic solutions that can transform precision oncology." …
Australian innovation could revolutionise the early detection of ovarian cancer
June 2, 2025 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Arrotex launches newly developed treatment for Australians with common skin conditions on the PBS
June 3, 2025 - - Latest News -
BMS Australia celebrates silver tier employer status at Australian LGBTQ+ Inclusion Awards
June 3, 2025 - - Latest News -
Sandoz calls for reforms to unlock biosimilar savings
June 3, 2025 - - Latest News -
TGA approves Lilly's GLP-1/GIP receptor for obstructive sleep apnoea
June 3, 2025 - - Latest News -
The needed realignment of belief, certainty and scepticism in our decision-making
June 3, 2025 - - Latest News -
Health department admits review of blood arrangements considering defunding products
June 3, 2025 - - Latest News -
New data uncovers our most painful moments as access to treatment expands
June 2, 2025 - - Latest News